Vasopressor Management in Hypotension

Introduction to Vasopressor Therapy

The American College of Critical Care Medicine recommends norepinephrine as the first-line vasopressor for hypotension, with an initial dose of 0.02 mg/kg/min that can be titrated up to 0.1-0.2 mg/kg/min to maintain a mean arterial pressure (MAP) ≥65 mmHg 1, 2, 3
The goal is to maintain a MAP ≥65 mmHg, although this value should be individualized based on comorbidities, such as pre-existing hypertension 4, 5

First-Line Vasopressors

Norepinephrine should be administered via central intravenous line whenever possible, although it can be started peripherally while awaiting central access 6
Vasopressin can be added to norepinephrine (not as initial monotherapy) to increase MAP or reduce norepinephrine dose, with a dose of up to 0.03 U/min 1, 2, 3, 7

Second-Line Vasopressors

Epinefrina is an alternative when an additional agent is needed, particularly in patients with myocardial dysfunction due to its inotropic effect 1, 2, 3, 4
Dopamina may be considered in highly selected patients, such as those with low risk of tachyarrhythmias and absolute or relative bradycardia, but it is not recommended for renal protection and is associated with a higher risk of arrhythmias compared to norepinephrine 1, 2, 3, 4, 7

Alternative Vasopressors

Fenilefrina has limited use, only in specific circumstances, such as when norepinephrine causes severe arrhythmias or when cardiac output is high but blood pressure remains low 4, 7

Practical Considerations

Placement of an arterial catheter is recommended as soon as possible in all patients requiring vasopressors 7
Adequate fluid resuscitation is essential before initiating vasopressors, although in severe shock, they may be started simultaneously 4, 5
Continuous monitoring of ECG, blood pressure, oxygen saturation, and diuresis is necessary 8
Evaluation of perfusion should be done using lactate levels, cutaneous perfusion, mental status, and diuresis 4, 5

Special Situations

In cardiogenic shock, consider dobutamina (2.5-10 μg/kg/min) if there is evidence of low cardiac output 8
In patients with persistent hypoperfusion despite fluids and vasopressors, consider dobutamina 7
In obstetric shock, norepinephrine remains the first choice, but a more restrictive approach to fluid resuscitation should be considered 6

Pre-Vasopressor Checklist for Hypotension

Critical Steps Before Starting Vasopressors

The Society of Critical Care Medicine recommends administering a minimum of 30 mL/kg of crystalloid fluids as an initial fluid challenge in patients with sepsis-induced tissue hypoperfusion and suspected hypovolemia 9
The European Society of Intensive Care Medicine suggests that blood volume depletion must be corrected as fully as possible before any vasopressor is administered, though in emergency situations where cerebral or coronary ischemia is imminent, vasopressors can be started concurrently with volume replacement 10, 9
Continue fluid administration as long as hemodynamic improvement occurs, using either dynamic parameters or static variables, as recommended by the American College of Critical Care Medicine 9

Monitoring and Preparation

The American College of Cardiology recommends placing an arterial catheter as soon as practical in all patients requiring vasopressors for continuous blood pressure monitoring 10, 11, 12

Common Pitfalls to Avoid

The Society of Critical Care Medicine advises never using vasopressors as a substitute for adequate fluid resuscitation, as this leads to excessive vasoconstriction and organ ischemia without addressing the underlying hypovolemia 9
The European Society of Intensive Care Medicine strongly discourages the use of dopamine for renal protection, as it provides no benefit 10, 11, 12

Target Parameters Before Starting Vasopressors

The American Heart Association recommends an initial MAP target of 65 mmHg once vasopressors are initiated 10, 9
The Society of Critical Care Medicine suggests supplementing blood pressure targets with assessment of regional perfusion, including lactate levels, skin perfusion, mental status, and urine output 9

Vasopressor Management in Hypotensive Patients

Special Considerations for Trauma Patients

In trauma patients with hemorrhagic shock, the American College of Surgeons recommends prioritizing restricted volume replacement with permissive hypotension, targeting a systolic BP of 80-90 mmHg, until bleeding is controlled, adding norepinephrine only if systolic BP falls below 80 mmHg, according to the Critical Care guideline 13
The Critical Care society suggests using 0.9% sodium chloride or balanced crystalloid solution for initial fluid resuscitation in trauma patients, and avoiding hypotonic solutions like Ringer's lactate in patients with severe head trauma 13
The Critical Care guideline recommends adding norepinephrine only when restricted volume replacement fails to achieve target BP and systolic pressure drops below 80 mmHg in trauma patients 13
Consider low-dose arginine vasopressin to decrease blood product requirements in severe hemorrhagic shock, as suggested by the Critical Care guideline 13
The Critical Care society recommends infusing dobutamine when myocardial dysfunction is present in trauma patients 13, 14
Avoid restricting colloids due to adverse effects on hemostasis in trauma patients, as recommended by the Critical Care guideline 13

Norepinephrine Use in Refractory Hypotension

Clinical Context and Timing

The European trauma guidelines recommend an initial strategy of restricted volume replacement targeting systolic BP 80-90 mmHg until bleeding is controlled, with norepinephrine indication for transient use only when systolic BP drops below 80 mmHg to maintain life and tissue perfusion, in patients with hemorrhagic shock 15, 16
The European trauma guidelines also recommend that systolic BP 80-90 mmHg does not represent life-threatening hypotension, and premature vasopressor use may worsen organ perfusion through excessive vasoconstriction, in patients with hemorrhagic shock 15, 16
For septic patients, norepinephrine is the first-line vasopressor when MAP <65 mmHg persists despite adequate fluid resuscitation, with the goal of maintaining mean arterial pressure (MAP) ≥65 mmHg, according to the Surviving Sepsis Campaign guidelines 17, 18
The Surviving Sepsis Campaign guidelines recommend targeting MAP ≥65 mmHg, which may need to be higher in patients with chronic hypertension, and early vasopressor use reduces organ failure incidence, in septic patients 17, 18

Evidence Quality and Strength

The recommendation for norepinephrine use carries a Grade 1C recommendation in trauma, which is a strong recommendation with low-quality evidence, and Grade B-E recommendations in sepsis, depending on the specific clinical question 15, 16, 18

Practical Implementation Algorithm

The American College of Critical Care Medicine recommends confirming adequate volume status, with minimum 30 mL/kg crystalloid in sepsis, and appropriate blood product replacement in hemorrhagic shock, before initiating norepinephrine 15, 16, 19
The American College of Critical Care Medicine recommends determining blood pressure thresholds, with initiation of norepinephrine only if systolic BP <80 mmHg in trauma without TBI/spinal injury, and if MAP <65 mmHg in septic shock or trauma with TBI, and monitoring for improvement in MAP, urine output, and lactate clearance 15, 16, 17, 18

Adjunctive Considerations

The Surviving Sepsis Campaign guidelines recommend adding vasopressin if hypotension persists despite norepinephrine, particularly in septic shock, and considering dobutamine if myocardial dysfunction is present with low cardiac output despite adequate preload and MAP 15, 16, 17, 18

Vasopressor Management in the ICU

First-Line Vasopressor Selection

Norepinephrine is the first-choice vasopressor for all forms of shock in the ICU, with a target MAP of 65 mmHg as the initial goal, as recommended by the Society of Critical Care Medicine 20, 21
Place an arterial catheter as soon as practical for continuous blood pressure monitoring in all patients requiring vasopressors, according to the Society of Critical Care Medicine 20, 22

Critical Pre-Vasopressor Requirements

Administer a minimum of 30 mL/kg crystalloid fluid bolus before starting vasopressors, except in emergency situations where cerebral or coronary ischemia is imminent, as suggested by the Society of Critical Care Medicine 20, 21
Continue fluid administration as long as hemodynamic improvement occurs, using dynamic parameters rather than static measures like CVP alone, as recommended by the Society of Critical Care Medicine 20, 21

MAP Targets and Individualization

Target MAP ≥65 mmHg for most patients, but increase to 70-75 mmHg in patients with chronic hypertension, according to the Society of Critical Care Medicine 20, 21
In elderly patients >75 years, consider lower MAP targets of 60-65 mmHg, which may reduce mortality, as suggested by the Society of Critical Care Medicine 21
MAP alone is insufficient—monitor lactate clearance, urine output, mental status, skin perfusion, and capillary refill, as recommended by the Society of Critical Care Medicine 20, 21

Second-Line Vasopressor Options

Add vasopressin 0.03 units/min when norepinephrine alone fails to achieve target MAP or to reduce norepinephrine dose, as suggested by the Society of Critical Care Medicine 22
Consider epinephrine as an alternative second agent, particularly when myocardial dysfunction is present due to its inotropic effects, according to the Society of Critical Care Medicine 20
Epinephrine can be added to or substituted for norepinephrine, as recommended by the Society of Critical Care Medicine 20

Agents to Avoid or Use Sparingly

Do not use dopamine for renal protection—it provides no benefit and increases arrhythmia risk compared to norepinephrine, as stated by the Society of Critical Care Medicine 22

Inotropic Support

Add dobutamine 2.5-10 µg/kg/min when evidence of low cardiac output persists despite adequate MAP and fluid resuscitation, as suggested by the Society of Critical Care Medicine 22
Dobutamine is the first-choice inotrope for measured or suspected low cardiac output with adequate filling pressures, according to the Society of Critical Care Medicine 22

Critical Pitfalls to Avoid

Do not rely on CVP alone to guide fluid resuscitation—dynamic measures are superior, as recommended by the Society of Critical Care Medicine 20, 21
Avoid using dopamine for renal protection—it provides no benefit, as stated by the Society of Critical Care Medicine 22

Vasopressor Titration Strategy

Introduction to Vasopressor Therapy

The Surviving Sepsis Campaign guidelines establish norepinephrine as the mandatory first-choice vasopressor, and there is no compelling evidence to support starting multiple vasopressors simultaneously, as recommended by the Surviving Sepsis Campaign 23, 24

Sequential Vasopressor Escalation Protocol

The American College of Critical Care Medicine recommends starting with norepinephrine as the sole first-line vasopressor and titrating it up alone to achieve a MAP ≥65 mmHg before adding a second agent, with a strength of evidence based on expert opinion 23
When norepinephrine alone fails to achieve target MAP despite adequate fluid resuscitation, the Surviving Sepsis Campaign guidelines suggest adding vasopressin at 0.03 units/minute, with moderate-quality evidence supporting this approach 23
If hypotension persists despite norepinephrine plus vasopressin, the American Heart Association recommends adding epinephrine (0.05-2 mcg/kg/min) as the third vasopressor, based on low-quality evidence 23

Critical Pitfalls to Avoid

The Surviving Sepsis Campaign explicitly recommends against dopamine as first-line therapy, due to its association with more arrhythmias and higher mortality compared to norepinephrine, based on high-quality evidence 23

Monitoring Requirements During Titration

The American College of Critical Care Medicine recommends placing an arterial catheter as soon as practical for continuous blood pressure monitoring in all patients requiring vasopressors, with a strength of evidence based on expert opinion 23
Ensure adequate fluid resuscitation (minimum 30 mL/kg crystalloid) before or concurrent with vasopressor initiation, as recommended by the Surviving Sepsis Campaign, with moderate-quality evidence supporting this approach 23

When to Add Inotropic Support

If persistent hypoperfusion exists despite adequate MAP and vasopressor therapy, the American College of Cardiology recommends adding dobutamine (2.5-20 mcg/kg/min) rather than escalating vasopressors further, based on low-quality evidence 23
Dobutamine is indicated when myocardial dysfunction is evident with low cardiac output despite adequate filling pressures, as suggested by the American Heart Association, with moderate-quality evidence supporting this approach 23

Vasopressor Management in Shock

Initial Vasopressor Strategy

The American College of Cardiology recommends starting with norepinephrine as the sole first-line agent at 0.02 mcg/kg/min and titrating upward to achieve MAP ≥65 mmHg 25
Ensure adequate fluid resuscitation first: minimum 30 mL/kg crystalloid bolus within the first 3 hours, as recommended by the Society of Critical Care Medicine 25, 26
Place an arterial catheter as soon as practical for continuous blood pressure monitoring, according to the Critical Care Medicine guidelines 26

Threshold for Adding Second Vasopressor

Add vasopressin 0.03 units/min when norepinephrine reaches 0.1-0.2 mcg/kg/min without achieving target MAP, as suggested by the Mayo Clinic Proceedings and Critical Care Medicine 25, 26
Vasopressin should never be used as initial monotherapy—only as an adjunct to norepinephrine, according to the Critical Care Medicine guidelines 26

Third Vasopressor Selection

Add epinephrine (0.05-2 mcg/kg/min) as the third vasopressor, particularly when myocardial dysfunction is present due to its inotropic effects, as recommended by the Critical Care Medicine 26
Alternatively, consider adding dobutamine (2.5-20 mcg/kg/min) if persistent hypoperfusion exists despite adequate MAP, especially when low cardiac output is evident, according to the Critical Care Medicine guidelines 26

Agents to Avoid

Never use dopamine as first-line therapy—it is associated with higher mortality and more arrhythmias compared to norepinephrine, as stated by the Critical Care Medicine 26
Do not use dopamine for "renal protection"—this is strongly discouraged and provides no benefit, according to the Critical Care Medicine guidelines 26

Monitoring Beyond MAP Targets

MAP ≥65 mmHg alone is insufficient—assess tissue perfusion using lactate clearance, urine output, mental status, skin perfusion, and capillary refill, as recommended by the Mayo Clinic Proceedings and Critical Care Medicine 25, 26
Monitor lactate clearance (repeat within 6 hours if initially elevated), as suggested by the Mayo Clinic Proceedings and Critical Care Medicine 25, 26

Special Considerations for Obstetric Patients

Start norepinephrine at 0.02 mcg/kg/min to maintain MAP ≥65 mmHg in maternal sepsis with persistent hypotension after 1-2L fluid bolus, as recommended by the Mayo Clinic Proceedings 25
Add vasopressin 0.04 units/min if MAP remains inadequate despite low-moderate dose norepinephrine (0.1-0.2 mcg/kg/min) in obstetric patients, according to the Mayo Clinic Proceedings 25

Inotrope and Vasopressor Initiation in Septic Patients

Introduction to Inotrope and Vasopressor Use

The American College of Critical Care Medicine recommends initiating inotropes when mean arterial pressure (MAP) ≥65 mmHg has been achieved with adequate fluid resuscitation and vasopressors, but persistent hypoperfusion remains evident by low cardiac output with ScvO2 <70%, elevated lactate, or signs of organ dysfunction, as stated by the Surviving Sepsis Campaign guidelines 27, 28
The Society of Critical Care Medicine suggests that vasopressors, such as norepinephrine, should be initiated when MAP <65 mmHg despite adequate fluid resuscitation, with a target MAP of ≥65 mmHg 27, 29, 30

Vasopressor Initiation and Management

The French Intensive Care Societies recommend starting vasopressors when MAP <65 mmHg persists after initial fluid resuscitation, with norepinephrine as the first-choice vasopressor (Grade 1B) 27, 29, 30
The World Journal of Emergency Surgery notes that in life-threatening hypotension, vasopressors may be started simultaneously with fluid resuscitation rather than waiting for complete volume repletion 27, 29

Inotrope Initiation Criteria

The Critical Care Medicine journal states that inotropes are indicated when cardiac output remains low despite achieving adequate MAP and filling pressures, with a primary indication being low cardiac output with ScvO2 <70% despite MAP ≥65 mmHg and adequate fluid resuscitation 28
The Surviving Sepsis Campaign guidelines suggest that dobutamine should be started at 2.5 mcg/kg/min and titrated up to 10-20 mcg/kg/min based on response, with a combination of dobutamine plus norepinephrine as the first-line inotrope/vasopressor strategy 28

Special Considerations

The American College of Critical Care Medicine recommends that patients with cardiovascular disease may require higher MAP targets (70-75 mmHg) due to impaired autoregulation from atherosclerosis, and are more likely to develop myocardial dysfunction requiring inotropic support 27, 31
The Critical Care journal notes that epinephrine can be added to or substituted for norepinephrine when additional vasopressor effect is needed (Grade 2B), with dosing at 0.05-2 mcg/kg/min for septic shock 27, 30

Vasopressor and Inotropic Strategies in Hemorrhagic Shock

Vasopressin as Second‑Line Agent

In patients with hemorrhagic shock whose systolic blood pressure remains < 80 mmHg despite norepinephrine titrated to 0.1–0.2 µg/kg/min, adding vasopressin at 0.03 units/min (as an adjunct, not as monotherapy) can help maintain perfusion pressure while definitive hemorrhage control is pursued. 32

Dobutamine for Documented Myocardial Dysfunction

Dobutamine should be initiated only when echocardiography or other cardiac monitoring demonstrates myocardial dysfunction with low cardiac output despite adequate preload and a mean arterial pressure ≥ 65 mmHg; it is not a first‑line agent for volume‑loss‑driven hypotension. [32][33]
The recommended dosing range is 2.5–10 µg/kg/min, titrated to achieve target perfusion endpoints (e.g., improved lactate clearance, urine output). 32

Dopamine – Recommendation to Avoid

Dopamine provides no renal protective benefit and is associated with a higher risk of arrhythmias compared with norepinephrine; therefore, it should be avoided entirely in the management of hemorrhagic shock. [32][33]

Phenylephrine – Very Limited Role

Phenylephrine may be considered only in two narrow scenarios: (1) when norepinephrine induces severe arrhythmias, or (2) when the patient has documented high cardiac output with persistent hypotension despite other vasopressors. 33

First‑Line Vasopressor Management and Adjunctive Therapies in Traumatic Intracranial Hemorrhage

Escalation of Vasopressor Therapy

Dobutamine should be added (2.5–20 µg/kg/min) when mean arterial pressure is adequate but signs of ongoing tissue hypoperfusion persist (elevated lactate, reduced urine output, altered mental status), especially if myocardial dysfunction is suspected after cardiac contusion or secondary to elevated intracranial pressure. 34

Cardiac Function Assessment

Bedside echocardiography is recommended to evaluate left‑ventricular function in trauma patients, as cardiac dysfunction may occur after cardiac contusion or as a consequence of severe brain injury with intracranial hypertension. 34
In the absence of direct cardiac output monitoring, clinicians should suspect myocardial dysfunction when the patient shows a poor hemodynamic response to fluid resuscitation and norepinephrine. 34

Hemodynamic Strategy for TBI Patients

Norepinephrine should be introduced transiently to maintain arterial pressure and ensure adequate tissue perfusion in patients with traumatic brain injury who develop life‑threatening hypotension, even if intravascular volume has not yet been fully restored. 34

Temperature Management

Early active warming to achieve normothermia is advised because hypothermia is linked to metabolic acidosis, hypotension, and coagulopathy in severely injured patients. 34
After hemorrhage control, therapeutic hypothermia (target 33–35 °C) may be considered for at least 48 hours in patients with traumatic brain injury. 34